18F-FDG PET/CT imaging in oncology.

Almuhaideb A, Papathanasiou N, Bomanji J. · 2011

Read 18F-FDG PET/CT imaging in oncology. by Almuhaideb A, Papathanasiou N, Bomanji J. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3101722.txt.

Description

Almuhaideb, Papathanasiou, and Bomanji reviewed in 2011 the role of combined PET and CT scanning with a radioactive sugar tracer in cancer care. Cancer cells consume sugar greedily, so the tracer lights them up, while the paired CT scan pins each hot spot to exact anatomy in the same session. The review guides oncologists and surgeons on where this imaging earns its cost.

Its strongest uses are staging cancers before treatment, rechecking them after, and hunting recurrences when blood markers rise but ordinary scans show nothing. It can also reveal early whether a treatment is working, before tumors shrink, allowing failing regimens to change sooner. Across studies, scan results altered the planned management in roughly a quarter of patients. The authors sort the evidence cancer by cancer, noting where the method is proven and where it overpromises.

Catalog record

CREATORAlmuhaideb A, Papathanasiou N, Bomanji J.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE53 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3101722

Browse the full library · About the Tower of Babel